US Patent:
20230102927, Mar 30, 2023
Inventors:
- Foster City CA, US
James S. Cassidy - San Francisco CA, US
Elbert Chin - San Mateo CA, US
Chienhung Chou - Dublin CA, US
Jeromy J. Cottell - Redwood City CA, US
Chao-I Hung - San Mateo CA, US
Kavoos Kolahdouzan - San Francisco CA, US
David W. Lin - Berkeley CA, US
Michael L. Mitchell - Castro Valley CA, US
Ezra Roberts - San Francisco CA, US
Scott D. Schroeder - Union City CA, US
Nathan D. Shapiro - Belmont CA, US
James G. Taylor - Burlingame CA, US
Nathan E. Wright - San Diego CA, US
Zheng-Yu Yang - Palo Alto CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
C07D 405/14
C07D 401/14
C07D 401/10
C07D 401/08
C07D 471/04
A61K 31/4439
C07D 491/048
A61K 31/497
A61K 31/437
A61K 31/506
A61K 31/5377
C07D 409/14
C07D 493/08
C07D 493/10
C07D 417/14
C07F 9/6558
A61K 31/675
Abstract:
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.